PI3K and cancer: lessons, challenges and opportunities
DADavid A. FrumanCRChristian Rommel
University of California, Irvine · Amgen (United States)
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,723
total citations
- FWCI
- 102.33
- Percentile
- 100%
- References
- 232
Citations per year
Authors
2- DADavid A. FrumanCorresponding
University of California, Irvine
- CRChristian RommelCorresponding
Amgen (United States)
Topics & keywords
Topics
Keywords
- PI3K/AKT/mTOR pathway
- Protein kinase B
- Cancer
- Discovery and development of mTOR inhibitors
- Cancer research
- Kinase
- Computational biology
- Biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.